IgG4-related disease–like fibrosis as an indicator of IgG4-related lymphadenopathy

Abstract The significance of IgG4-related diseases including IgG4-related lymphadenopathy has recently been recognized worldwide. Inflammatory pseudotumors in lymph nodes, as well as in other organs, are also recognized as IgG4-related diseases. Only a few case reports have described IgG4-related ly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of diagnostic pathology 2013-10, Vol.17 (5), p.416-420
Hauptverfasser: Uehara, Takeshi, MD, PhD, Masumoto, Junya, MD, PhD, Yoshizawa, Akihiko, MD, PhD, Kobayashi, Yukihiro, MT, PhD, Hamano, Hideaki, MD, PhD, Kawa, Shigeyuki, MD, PhD, Oki, Keiko, MT, Oikawa, Nao, MT, Honda, Takayuki, MD, PhD, Ota, Hiroyoshi, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 420
container_issue 5
container_start_page 416
container_title Annals of diagnostic pathology
container_volume 17
creator Uehara, Takeshi, MD, PhD
Masumoto, Junya, MD, PhD
Yoshizawa, Akihiko, MD, PhD
Kobayashi, Yukihiro, MT, PhD
Hamano, Hideaki, MD, PhD
Kawa, Shigeyuki, MD, PhD
Oki, Keiko, MT
Oikawa, Nao, MT
Honda, Takayuki, MD, PhD
Ota, Hiroyoshi, MD, PhD
description Abstract The significance of IgG4-related diseases including IgG4-related lymphadenopathy has recently been recognized worldwide. Inflammatory pseudotumors in lymph nodes, as well as in other organs, are also recognized as IgG4-related diseases. Only a few case reports have described IgG4-related lymphadenopathy with fibrosis (IgG4-fibrosing lymphadenopathy), and IgG4-fibrosing lymphadenopathy has not been compared clinicopathologically with non–IgG4-related lymphadenopathy with fibrosis. We have evaluated the pathologic features in 13 patients with IgG4-fibrosing lymphadenopathy, including IgG4 and IgG expression in lymph nodes, and compared these features with those of patients with non–IgG4-related lymphadenopathy with fibrosis with reactive inguinal lymphadenopathy and focal fibrosis and lymph nodes at least 10 mm in diameter. IgG4-fibrosing lymphadenopathy was characterized by lymphoplasmacytic and eosinophilic infiltration, many IgG4-positive plasma cells in fibrotic areas, and high serum IgG4 concentrations. The IgG4-positive/IgG-positive plasma cell ratio was significantly higher in the IgG4-fibrosing lymphadenopathy than in the non–IgG4-fibrosing lymphadenopathy group. The presence of even minor fibrosis with characteristics of IgG4-related disease such as IgG4-fibrosing lymphadenopathy may facilitate the diagnosis of IgG4-related lymphadenopathy.
doi_str_mv 10.1016/j.anndiagpath.2013.04.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1433275148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1092913413000336</els_id><sourcerecordid>1433275148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-a11ed422014d5d0d506ec222d55d5fac3c659f3e1dcc128039ea9da8184ee7213</originalsourceid><addsrcrecordid>eNqNkc9OGzEQxi0EIjTwCmh747LbGf9Jdi-VqqhQpEg9AGfLsWeJk81usDdIufUdeMM-Sb0KVLQnJEvjw_fNN_Mbxj4jFAg4-bIqTNs6bx63pl8WHFAUIAtAOGJnqATPS6zK4_SHiucVCjlin2JcASBKNT1lIy6mwAXnZ-z-9vFG5oEa05PLnI9kIv3-9dL4NWW1X4Qu-piZ9NrMp0xr-i5kXZ3942v2m-3SOGq7YaL9OTupTRPp4rWO2cP19_vZj3z-8-Z29m2eWyl4nxtEcpKn-aVTDpyCCVnOuVPKqdpYYSeqqgWhsxZ5CaIiUzlTYimJphzFmF0d-m5D97Sj2OuNj5aaxrTU7aJGKQSfKpRlklYHqU0bxUC13ga_MWGvEfQAVa_0O6h6gKpB6gQ1eS9fY3aLDbm_zjeKSTA7CCgt--wp6Gg9tZacD2R77Tr_oZiv_3WxjW8T8WZNe4qrbhfaRFOjjlyDvhuuOxwXBQAIMRF_AKlvo6E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1433275148</pqid></control><display><type>article</type><title>IgG4-related disease–like fibrosis as an indicator of IgG4-related lymphadenopathy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Uehara, Takeshi, MD, PhD ; Masumoto, Junya, MD, PhD ; Yoshizawa, Akihiko, MD, PhD ; Kobayashi, Yukihiro, MT, PhD ; Hamano, Hideaki, MD, PhD ; Kawa, Shigeyuki, MD, PhD ; Oki, Keiko, MT ; Oikawa, Nao, MT ; Honda, Takayuki, MD, PhD ; Ota, Hiroyoshi, MD, PhD</creator><creatorcontrib>Uehara, Takeshi, MD, PhD ; Masumoto, Junya, MD, PhD ; Yoshizawa, Akihiko, MD, PhD ; Kobayashi, Yukihiro, MT, PhD ; Hamano, Hideaki, MD, PhD ; Kawa, Shigeyuki, MD, PhD ; Oki, Keiko, MT ; Oikawa, Nao, MT ; Honda, Takayuki, MD, PhD ; Ota, Hiroyoshi, MD, PhD</creatorcontrib><description>Abstract The significance of IgG4-related diseases including IgG4-related lymphadenopathy has recently been recognized worldwide. Inflammatory pseudotumors in lymph nodes, as well as in other organs, are also recognized as IgG4-related diseases. Only a few case reports have described IgG4-related lymphadenopathy with fibrosis (IgG4-fibrosing lymphadenopathy), and IgG4-fibrosing lymphadenopathy has not been compared clinicopathologically with non–IgG4-related lymphadenopathy with fibrosis. We have evaluated the pathologic features in 13 patients with IgG4-fibrosing lymphadenopathy, including IgG4 and IgG expression in lymph nodes, and compared these features with those of patients with non–IgG4-related lymphadenopathy with fibrosis with reactive inguinal lymphadenopathy and focal fibrosis and lymph nodes at least 10 mm in diameter. IgG4-fibrosing lymphadenopathy was characterized by lymphoplasmacytic and eosinophilic infiltration, many IgG4-positive plasma cells in fibrotic areas, and high serum IgG4 concentrations. The IgG4-positive/IgG-positive plasma cell ratio was significantly higher in the IgG4-fibrosing lymphadenopathy than in the non–IgG4-fibrosing lymphadenopathy group. The presence of even minor fibrosis with characteristics of IgG4-related disease such as IgG4-fibrosing lymphadenopathy may facilitate the diagnosis of IgG4-related lymphadenopathy.</description><identifier>ISSN: 1092-9134</identifier><identifier>EISSN: 1532-8198</identifier><identifier>DOI: 10.1016/j.anndiagpath.2013.04.010</identifier><identifier>PMID: 23702322</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Female ; Fibrosis - immunology ; Fibrosis - pathology ; Humans ; IgG4-positive plasma cell/IgG-positive plasma cell ratio ; IgG4-related diseases ; IgG4-related lymphadenopathy ; IgG4-related lymphadenopathy with fibrosis ; Immunoglobulin G - immunology ; Immunohistochemistry ; Inflammation - immunology ; Inflammation - pathology ; Lymphatic Diseases - immunology ; Lymphatic Diseases - pathology ; Male ; Middle Aged ; Pathology</subject><ispartof>Annals of diagnostic pathology, 2013-10, Vol.17 (5), p.416-420</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-a11ed422014d5d0d506ec222d55d5fac3c659f3e1dcc128039ea9da8184ee7213</citedby><cites>FETCH-LOGICAL-c432t-a11ed422014d5d0d506ec222d55d5fac3c659f3e1dcc128039ea9da8184ee7213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.anndiagpath.2013.04.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23702322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uehara, Takeshi, MD, PhD</creatorcontrib><creatorcontrib>Masumoto, Junya, MD, PhD</creatorcontrib><creatorcontrib>Yoshizawa, Akihiko, MD, PhD</creatorcontrib><creatorcontrib>Kobayashi, Yukihiro, MT, PhD</creatorcontrib><creatorcontrib>Hamano, Hideaki, MD, PhD</creatorcontrib><creatorcontrib>Kawa, Shigeyuki, MD, PhD</creatorcontrib><creatorcontrib>Oki, Keiko, MT</creatorcontrib><creatorcontrib>Oikawa, Nao, MT</creatorcontrib><creatorcontrib>Honda, Takayuki, MD, PhD</creatorcontrib><creatorcontrib>Ota, Hiroyoshi, MD, PhD</creatorcontrib><title>IgG4-related disease–like fibrosis as an indicator of IgG4-related lymphadenopathy</title><title>Annals of diagnostic pathology</title><addtitle>Ann Diagn Pathol</addtitle><description>Abstract The significance of IgG4-related diseases including IgG4-related lymphadenopathy has recently been recognized worldwide. Inflammatory pseudotumors in lymph nodes, as well as in other organs, are also recognized as IgG4-related diseases. Only a few case reports have described IgG4-related lymphadenopathy with fibrosis (IgG4-fibrosing lymphadenopathy), and IgG4-fibrosing lymphadenopathy has not been compared clinicopathologically with non–IgG4-related lymphadenopathy with fibrosis. We have evaluated the pathologic features in 13 patients with IgG4-fibrosing lymphadenopathy, including IgG4 and IgG expression in lymph nodes, and compared these features with those of patients with non–IgG4-related lymphadenopathy with fibrosis with reactive inguinal lymphadenopathy and focal fibrosis and lymph nodes at least 10 mm in diameter. IgG4-fibrosing lymphadenopathy was characterized by lymphoplasmacytic and eosinophilic infiltration, many IgG4-positive plasma cells in fibrotic areas, and high serum IgG4 concentrations. The IgG4-positive/IgG-positive plasma cell ratio was significantly higher in the IgG4-fibrosing lymphadenopathy than in the non–IgG4-fibrosing lymphadenopathy group. The presence of even minor fibrosis with characteristics of IgG4-related disease such as IgG4-fibrosing lymphadenopathy may facilitate the diagnosis of IgG4-related lymphadenopathy.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Fibrosis - immunology</subject><subject>Fibrosis - pathology</subject><subject>Humans</subject><subject>IgG4-positive plasma cell/IgG-positive plasma cell ratio</subject><subject>IgG4-related diseases</subject><subject>IgG4-related lymphadenopathy</subject><subject>IgG4-related lymphadenopathy with fibrosis</subject><subject>Immunoglobulin G - immunology</subject><subject>Immunohistochemistry</subject><subject>Inflammation - immunology</subject><subject>Inflammation - pathology</subject><subject>Lymphatic Diseases - immunology</subject><subject>Lymphatic Diseases - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pathology</subject><issn>1092-9134</issn><issn>1532-8198</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc9OGzEQxi0EIjTwCmh747LbGf9Jdi-VqqhQpEg9AGfLsWeJk81usDdIufUdeMM-Sb0KVLQnJEvjw_fNN_Mbxj4jFAg4-bIqTNs6bx63pl8WHFAUIAtAOGJnqATPS6zK4_SHiucVCjlin2JcASBKNT1lIy6mwAXnZ-z-9vFG5oEa05PLnI9kIv3-9dL4NWW1X4Qu-piZ9NrMp0xr-i5kXZ3942v2m-3SOGq7YaL9OTupTRPp4rWO2cP19_vZj3z-8-Z29m2eWyl4nxtEcpKn-aVTDpyCCVnOuVPKqdpYYSeqqgWhsxZ5CaIiUzlTYimJphzFmF0d-m5D97Sj2OuNj5aaxrTU7aJGKQSfKpRlklYHqU0bxUC13ga_MWGvEfQAVa_0O6h6gKpB6gQ1eS9fY3aLDbm_zjeKSTA7CCgt--wp6Gg9tZacD2R77Tr_oZiv_3WxjW8T8WZNe4qrbhfaRFOjjlyDvhuuOxwXBQAIMRF_AKlvo6E</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Uehara, Takeshi, MD, PhD</creator><creator>Masumoto, Junya, MD, PhD</creator><creator>Yoshizawa, Akihiko, MD, PhD</creator><creator>Kobayashi, Yukihiro, MT, PhD</creator><creator>Hamano, Hideaki, MD, PhD</creator><creator>Kawa, Shigeyuki, MD, PhD</creator><creator>Oki, Keiko, MT</creator><creator>Oikawa, Nao, MT</creator><creator>Honda, Takayuki, MD, PhD</creator><creator>Ota, Hiroyoshi, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131001</creationdate><title>IgG4-related disease–like fibrosis as an indicator of IgG4-related lymphadenopathy</title><author>Uehara, Takeshi, MD, PhD ; Masumoto, Junya, MD, PhD ; Yoshizawa, Akihiko, MD, PhD ; Kobayashi, Yukihiro, MT, PhD ; Hamano, Hideaki, MD, PhD ; Kawa, Shigeyuki, MD, PhD ; Oki, Keiko, MT ; Oikawa, Nao, MT ; Honda, Takayuki, MD, PhD ; Ota, Hiroyoshi, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-a11ed422014d5d0d506ec222d55d5fac3c659f3e1dcc128039ea9da8184ee7213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Fibrosis - immunology</topic><topic>Fibrosis - pathology</topic><topic>Humans</topic><topic>IgG4-positive plasma cell/IgG-positive plasma cell ratio</topic><topic>IgG4-related diseases</topic><topic>IgG4-related lymphadenopathy</topic><topic>IgG4-related lymphadenopathy with fibrosis</topic><topic>Immunoglobulin G - immunology</topic><topic>Immunohistochemistry</topic><topic>Inflammation - immunology</topic><topic>Inflammation - pathology</topic><topic>Lymphatic Diseases - immunology</topic><topic>Lymphatic Diseases - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uehara, Takeshi, MD, PhD</creatorcontrib><creatorcontrib>Masumoto, Junya, MD, PhD</creatorcontrib><creatorcontrib>Yoshizawa, Akihiko, MD, PhD</creatorcontrib><creatorcontrib>Kobayashi, Yukihiro, MT, PhD</creatorcontrib><creatorcontrib>Hamano, Hideaki, MD, PhD</creatorcontrib><creatorcontrib>Kawa, Shigeyuki, MD, PhD</creatorcontrib><creatorcontrib>Oki, Keiko, MT</creatorcontrib><creatorcontrib>Oikawa, Nao, MT</creatorcontrib><creatorcontrib>Honda, Takayuki, MD, PhD</creatorcontrib><creatorcontrib>Ota, Hiroyoshi, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of diagnostic pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uehara, Takeshi, MD, PhD</au><au>Masumoto, Junya, MD, PhD</au><au>Yoshizawa, Akihiko, MD, PhD</au><au>Kobayashi, Yukihiro, MT, PhD</au><au>Hamano, Hideaki, MD, PhD</au><au>Kawa, Shigeyuki, MD, PhD</au><au>Oki, Keiko, MT</au><au>Oikawa, Nao, MT</au><au>Honda, Takayuki, MD, PhD</au><au>Ota, Hiroyoshi, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IgG4-related disease–like fibrosis as an indicator of IgG4-related lymphadenopathy</atitle><jtitle>Annals of diagnostic pathology</jtitle><addtitle>Ann Diagn Pathol</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>17</volume><issue>5</issue><spage>416</spage><epage>420</epage><pages>416-420</pages><issn>1092-9134</issn><eissn>1532-8198</eissn><abstract>Abstract The significance of IgG4-related diseases including IgG4-related lymphadenopathy has recently been recognized worldwide. Inflammatory pseudotumors in lymph nodes, as well as in other organs, are also recognized as IgG4-related diseases. Only a few case reports have described IgG4-related lymphadenopathy with fibrosis (IgG4-fibrosing lymphadenopathy), and IgG4-fibrosing lymphadenopathy has not been compared clinicopathologically with non–IgG4-related lymphadenopathy with fibrosis. We have evaluated the pathologic features in 13 patients with IgG4-fibrosing lymphadenopathy, including IgG4 and IgG expression in lymph nodes, and compared these features with those of patients with non–IgG4-related lymphadenopathy with fibrosis with reactive inguinal lymphadenopathy and focal fibrosis and lymph nodes at least 10 mm in diameter. IgG4-fibrosing lymphadenopathy was characterized by lymphoplasmacytic and eosinophilic infiltration, many IgG4-positive plasma cells in fibrotic areas, and high serum IgG4 concentrations. The IgG4-positive/IgG-positive plasma cell ratio was significantly higher in the IgG4-fibrosing lymphadenopathy than in the non–IgG4-fibrosing lymphadenopathy group. The presence of even minor fibrosis with characteristics of IgG4-related disease such as IgG4-fibrosing lymphadenopathy may facilitate the diagnosis of IgG4-related lymphadenopathy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23702322</pmid><doi>10.1016/j.anndiagpath.2013.04.010</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1092-9134
ispartof Annals of diagnostic pathology, 2013-10, Vol.17 (5), p.416-420
issn 1092-9134
1532-8198
language eng
recordid cdi_proquest_miscellaneous_1433275148
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Aged
Aged, 80 and over
Female
Fibrosis - immunology
Fibrosis - pathology
Humans
IgG4-positive plasma cell/IgG-positive plasma cell ratio
IgG4-related diseases
IgG4-related lymphadenopathy
IgG4-related lymphadenopathy with fibrosis
Immunoglobulin G - immunology
Immunohistochemistry
Inflammation - immunology
Inflammation - pathology
Lymphatic Diseases - immunology
Lymphatic Diseases - pathology
Male
Middle Aged
Pathology
title IgG4-related disease–like fibrosis as an indicator of IgG4-related lymphadenopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T17%3A53%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IgG4-related%20disease%E2%80%93like%20fibrosis%20as%20an%20indicator%20of%20IgG4-related%20lymphadenopathy&rft.jtitle=Annals%20of%20diagnostic%20pathology&rft.au=Uehara,%20Takeshi,%20MD,%20PhD&rft.date=2013-10-01&rft.volume=17&rft.issue=5&rft.spage=416&rft.epage=420&rft.pages=416-420&rft.issn=1092-9134&rft.eissn=1532-8198&rft_id=info:doi/10.1016/j.anndiagpath.2013.04.010&rft_dat=%3Cproquest_cross%3E1433275148%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1433275148&rft_id=info:pmid/23702322&rft_els_id=1_s2_0_S1092913413000336&rfr_iscdi=true